INTRODUCTION
PER2, of the PER family of genes, is considered to play a critical role in behavioral rhythmicity. 12 Toh et al., 10 reported that the PER2 polymorphism at the CK1 binding loci was associated with familial advanced sleep phase syndrome (FASPS). This result suggests that the PER2 polymorphism is an essential factor in advanced sleep phase syndrome (ASPS), which has the characteristic of the shortening of the circadian period (tau). 10 Previous studies have reported the association of the PER3 polymorphism with morningness-eveningness (ME) preference, 11, 14 as well as delayed sleep phase syndrome (DSPS), 14 however, there has been no study on the relationship of the PER2 polymorphism with ME preference. In particular, it has been reported that the PER2 gene induced apoptosis through the upregulation of tumor suppressor genes, and that the PER2 gene mutation (S662G) found in ASPS affected tumor occurrence in rats. 15 When the CRY gene and the PER gene form a heterodimer, it plays an important role in the modulation of circadian rhythm, 1 influencing cell growth. 1 Recent studies have shown a relationship between the risk of breast cancer and the polymorphisms of various sleep-related genes in female night shift workers. 15 The single nucleotide polymorphism (SNP) of the CRY1 G/T allele has also been linked to an increased risk of breast cancer in the general population. 16 To date, there has been no study on the relationship between the ME preference and the polymorphisms of the PER2 and CRY1 genes, which have been hypothesized to play an essential role in the modulation of circadian rhythm. We hypothesized that each polymorphism of PER2-2221A/G and CRY1-2790T/G would be associated with the ME preference in Korean adults. Our present study aims to examine the difference in the polymorphisms of PER2-2221A/G and CRY1-2790T/G according to the ME preference in the Korean adult population.
METHODS

Participants
The present study was conducted on subjects aged 18 years or older who visited the Chuncheon National Museum or the Health Promotion Center at Kangwon National University Hospital and Hyosung Hospital in Korea between May 2010 and February 2012. The Korean version of the Morningness-Eveningness Questionnaire (MEQ-K), 17 the Korean version of the Epworth Sleepiness Scale (KESS), 18 and the Pittsburgh Sleep Quality Index (PSQI) 19 translated into Korean, were administered to 2011 subjects. Buccal DNA samples were obtained from 400 subjects, who agreed to donate a buccal swab for the genetic study. The study protocol was approved by the Institutional Review Board at Kangwon National University Hospital. Written informed consent was obtained from each enrolled patient. All procedures were carried out in accordance with the principles of the Declaration of Helsinki.
Procedures
Standard scores on the MEQ were used to categorize subjects as morning type (MT), neither type (NT) or evening type (ET). The lower scores (16 to 41) indicated ET, the higher scores (59 to 86) indicated MT and a score of 42 to 58 indicated an NT.
Among the collected DNA samples (n = 400), there were only 62 samples from ET subjects. We selected the same number of samples (n = 62) from each of the MT and NT groups. 62 DNA samples were selected among the MT subjects in the order of highest MEQ-K scores, and 62 samples among the NT subjects according to an equal number before and after the median MEQ-K score of the NT group.
Two previously-reported SNPs, PER2 A2221G and CRY1 T2790G, which had not been associated with the ME type, were further pursued as candidate alleles for morning or evening preference, and were analyzed by DNA sequencing or a SNaPshot assay.
We excluded the subjects who were being treated for sleep disorders (n = 4) or those with shift work (n = 8). The data for 47 MT (age: 44.57 ± 12.33, M:F = 14:33) subjects, 59 NT (age: 35.20 ± 9.53, M:F = 20:39) subjects, and 51 ET (age: 28.80 ± 8.03, M:F = 14:37) subjects, were included in the final gene analysis after discarding 2 failed data.
Measures
DNA extraction and DNA sequencing process
The DNA samples were obtained from the saliva by buccal smear and stored at -80°C. The buccal swab procedure was conducted according to the manufacturer's instructions. Primer pairs were designed from the sequences, and were amplified using polymerase chain reaction (PCR). PCR primers and conditions used for the amplification of potential SNPs are shown in Table 1 . A Gene Amp PCR System 9700 (Applied Biosystems, Foster City, CA, USA) was used with an initial denaturation step of 95°C for 5 minutes, followed by 40 cycles of denaturation at 95°C for 15 seconds, annealing at 57°C or 48°C for 30 seconds, extension at 72°C for 30 seconds, and a final elongation step at 72°C for 3 minutes. Sequencing reactions were performed in both senses with a Big Dye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Foster City, CA, USA), and the same primers were used for sequencing analysis. Sequence reactions were run on the ABI PRISM 3700 DNA Automatic Analyzer (Applied Biosystems, Foster City, CA, USA).
SNaPshot assay
The genotyping was screened with a single base primer extension assay using the ABI PRISM SNaPShot Multiplex kit (ABI, Foster City, CA, USA) according to the manufacturer's recommendations. The PCR reactions were carried out as follows: 1 cycle at 95°C for 10 minutes, 35 cycles at 95°C for 30 seconds, 55°C for 1 minute, 72°C for 1 minute, followed by 1 cycle at 72°C for 10 minutes. After amplification, the amplified products were purified, and the primer extension reaction was carried out for 25 cycles at 96°C for 10 seconds, 50°C for 5 seconds, and 60°C for 30 seconds. The reaction products were analyzed by electrophoresis in an ABI Prism 3730xl DNA analyzer, and analysis was carried out using Gene Mapper (version 4.0; Applied Biosystems, Foster City, CA, USA).
Data Analysis
Observed genotype frequencies were compared with the expected Hardy-Weinberg equilibrium values using the chi-square test.
Demographic variables and scores of the MEQ-K, KESS, and PSQI in the MT, NT, and ET groups were compared by ANOVA with post hoc contrasts when controlling for the effect of the covariate age.
The genotype distributions, allele frequencies, and proportion of subjects with a risk allele in the MT, NT, and ET groups were compared using the chi-square test. Post hoc contrasts were performed for each group compared with the other two combined groups, and the odds ratios of the risk allele frequency were obtained for an appropriate group.
All statistical analyses were performed with the SPSS software package (version 18.0, SPSS Inc., Chicago, IL, USA). Two-sided p values below 0.05 were considered statistically significant.
RESULTS
Genotype frequencies of both PER2-2221A/G and CRY1-2790T/G did not deviate significantly from the Hardy-Weinberg equilibrium (χ 2 = 0.52, p = 0.77 for PER2; χ 2 = 0.01, p = 0.99 for CRY1).
There were significant differences in the means of age and education level between the MT, NT, and ET groups (p < 0.01). When controlling for the effect of the covariate age, there were significant differences in the mean scores of the MEQ-K (p < 0.0001) and PSQI (p = 0.05) between the MT, NT, and ET groups ( Table 2) .
For the PER2-2221A/G, there were significant differences in the genotype distribution, allele frequency, and proportion of G allele positive subjects between the MT, NT, and ET groups. From a post hoc test, neither the MT nor the ET group showed a significant difference in the AG genotype, G allele frequency, or proportion of G allele positive subjects compared with the other groups (Table 3) .
For the CRY1-2790T/G, there were no significant differences in the genotype distribution, allele frequency, or proportion of G allele positive subjects between the MT, NT, and ET groups (Table 4) .
For both the PER2-A2221A/G and CRY1-2790T/G polymorphisms, there was no significant difference in the mean scores of the MEQ-K, KESS, or PSQI between G allele positive and negative subjects.
DISCUSSION
Our present study shows statistical differences in the genotype distribution and allele frequency of PER2-2221A/G be- tween the MT, ET, and NT groups, however, this genetic difference was not found between the MT and ET groups (Table 3) . Toh et al., 10 originally reported that the PER2-2221A/G mutation within the casein kinase 1ε binding region of PER2 could be related to the pathophysiology of FASPS through the shortening of the circadian period.
If ASPS is considered pathologically as extreme morningness, 11, 20, 21 this SNP may be associated with the MT. Although our results showed that the proportion of G allele (PER2-2221A/ G) positive subjects in the MT group was a little higher than in the ET group [MT with G (+): 23.2%; ET with G (+): 17.9%], there was no statistical difference. Moreover, this result is consistent with a previous study in which it was shown that this mutation in FASPS is not found in the Japanese population. 9 There have been several studies on the association between PER gene variants and diurnal preference. 6, 7, 11, 14 However, the majority of subsequent recent studies regarding the PER gene could not replicate the original findings. These discrepancies may be responsible for the differences in the study population. 11, 14 We also investigated the association of the PER2-111C/ G polymorphism with diurnal preference in our study population. For the distribution of PER2-111C/G among the MT, NT, and ET groups, there were not any significant differences in genotypes, allele frequencies, or proportion of G allele positive subjects. This result was consistent with the study of Lee et al., 22 in 299 Korean college students, where an association of the PER2-3853G/A polymorphism (rs934945) with diurnal preference was seen, however, we have not yet investigated this in our sample.
We cannot yet conclude whether ASPS is merely an extreme of morningness on the continuum of diurnal preference. Previous pedigree studies have well illustrated that ASPS has an autosomal dominant feature with a high penetrance, additionally showing a short period in their endogenous rhythm. 23 The ME preference is not determined only by the endogenous rhythm, differing from circadian rhythm sleep disorders such as ASPS. 24 The ME preference is influenced by various demographic characteristics such as age, gender, living habits, and/or by psychological factors. Carpen et al., 7 showed that there was no difference in PER1-T2434C polymorphism between the MT and DSPS, while showing its difference between MT and ET. This reflects an existing difference in genetic features between diurnal preference and circadian rhythm sleep disorder. We certainly need to keep in mind that our study population was different from those of previous studies.
When we additionally analyzed diurnal preference and sleep quality according to the presence and absence of the PER2-2221G allele, no significant association between the PER2- Odd ratio is represented with the odds of risk allele in MT plus ET compared to NT. *p < 0.05, **p < 0.01 (χ 2 test). MT: morning type, NT: neither type, ET: evening type. Table 4 . Distribution of CRY1-2790T/G in the MT (n = 46), NT (n = 59) and ET (n = 51) groups CRY1-2790T/G Genotypes, n (%)
Allele frequencies G-Allele, n (%) 2221G allele and diurnal preference was found. However, G allele positive subjects had a tendency towards poor sleep quality (p = 0.059), and the PSQI scores of the NT subjects who had an extremely low incidence rate of the G allele were relatively lower (Table 2) . Recently, the associations between the polymorphisms of CLOCK and sleep quality were investigated, however, researchers failed to find a significant association. 25 It has been shown that MT subjects had better sleep quality compared with ET subjects, 26 but most studies did not report a difference in sleep quality in comparison with NT subjects. Some studies, including ours, suggest that NT subjects have better sleep quality than MT subjects. 17, 27 Our study shows that the occurrence rate of the PER2-2221A/ G polymorphism in the MT and ET groups was higher than in the NT group. This polymorphism could not separate the MT group from the ET group. It may be difficult to rule out the possibility that the phenotype due to the PER2 polymorphism is related to other circadian genes in our study. Therefore the genetic difference of PER2 in MT or ET subjects compared with NT subjects cannot be explained by our results alone, requiring further investigation.
Recently, the PER2 S662G mutation was reported to be linked to cell cycle progression and tumorigenesis. 28 Another study found that marked 24-hour rest-activity rhythms were associated with a better quality of life, better performance status, better response, and longer survival in patients with metastatic colorectal cancer. 29 Recently, significant and noteworthy associations between several polymorphisms in circadian genes and breast cancer risk were found among nurses who had worked at least three consecutive night shifts. 15 It was recently suggested that circadian disruption can cause various physical illnesses. Therefore, the genetic difference in CRY1-2790T/G between the MT and ET groups was examined, and no significant difference was found on the basis of the association of the CRY1 polymorphism with cancer risk (Table 4) .
Although the SNP examined in our study is located at the 3'-untranslated region, unrelated to the changes in the RNA structure or protein sequence, 7 it has been shown that the function and expression of gene products can be controlled by affecting the stability of the RNA transcript.
30-32 Although we did not succeed in illustrating an association between the CRY1 polymorphism and diurnal preference, it was notable that this study was the first to examine this association. It has been reported that the knockout of Cry1 and Cry2 at the animal level led to a short and long period phenotype, respectively. 33, 34 However, there have been no human studies on the association of the CRY1 gene with the sleep phase syndrome or ME preference. It has only been reported that the RNA expression of the clock gene was examined for 24 hours in the buccal mucosa and the tissue from a skin biopsy, and the expression of the CRY1 gene showed a circadian pattern in line with those of the PER1 and Bmal1 genes. 35 There are some limitations of the present study. Firstly, we should have considered the endogenous rhythm in addition to the self-questionnaire when determining the ME types. Therefore, a future study would be required on the association of ME preference with genetic polymorphism, measuring the endogenous rhythm in the subjects with DMT and DET, in order to verify our results.
Secondly, a post hoc power analysis revealed that the statistical power for CRY1-2790T/G obtained in our sample size was approximately 0.21, even though the statistical power for PER2-2221 A/G was more than 0.99, indicating a sufficient sample size. Accordingly, the limited statistical power imposed by the modest sample size in the present study may have played a role in the non-significance of the statistical comparisons for CRY1-2790T/G.
In summary, we did not identify the genetic difference of PER 2-2221A/G between the MT and ET groups, although the MT and ET groups showed such a difference from the NT group. We also failed to find the association of the CRY1-2790T/G polymorphism with diurnal preference.
However, our study was the first in an Asian adult population to examine the association of the ME preference with the PER2-2221A/G and CRY1-2790T/G polymorphisms, which may play key roles in the modulation of circadian rhythm. In the future, the relationship of the PER2-3853G/A polymorphism with diurnal preference needs to be investigated in the Korean adult population.
